Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse

By Eyles J.E.   Sharp G.J.E.   Williamson E.D.   Spiers I.D.   Alpar H.O.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 698-707

Elsevier

Access to resources Recommend Favorite

Protection studies following bronchopulmonary and intramuscular immunisation with Yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy

By Eyles J.E.   Williamson E.D.   Spiers I.D.   Alpar H.O.  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3266-3271

Elsevier

Access to resources Recommend Favorite

Immune responses to V antigen of Yersinia pestis co-encapsulated with IFN- : effect of dose and formulation

By Griffin K.F.   Conway B.R.   Alpar H.O.   Williamson E.D.  

Vaccine, Vol. 16, Iss. 5, 1998-03 ,pp. : 517-521

Elsevier

Access to resources Recommend Favorite

Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Taniguchi T.   Kozuka S.   Matano K.   Maeyama J.-i.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1165-1173

Elsevier

Access to resources Recommend Favorite

Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine

By Greenbaum E.   Furst A.   Kiderman A.   Stewart B.   Levy R.   Schlesinger M.   Morag A.   Zakay-Rones Z.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1232-1239

Elsevier

Access to resources Recommend Favorite